Terms: = Brain cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
3897 results:
1. Novel 9-Methylanthracene Derivatives as p53 Activators for the Treatment of Glioblastoma Multiforme.
Feng Y; Wang Y; Li X; Sun Z; Qiang S; Wang H; Liu Y
Molecules; 2024 May; 29(10):. PubMed ID: 38792257
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
[TBL] [Abstract] [Full Text] [Related]
4. AQP8 Modulates Mitochondrial H
Shen Z; Sheng H; Zhao J; Xu J; Cai Z; Zhang H; Guo Z; Liu J; Liang H; Tan L; Gan S; Huang J; Zhu S
Cancer Invest; 2024 Apr; 42(4):345-356. PubMed ID: 38742677
[TBL] [Abstract] [Full Text] [Related]
5. Genetic variants for head size share genes and pathways with cancer.
Knol MJ; Poot RA; Evans TE; Satizabal CL; Mishra A; Sargurupremraj M; van der Auwera S; Duperron MG; Jian X; Hostettler IC; van Dam-Nolen DHK; Lamballais S; Pawlak MA; Lewis CE; Carrion-Castillo A; van Erp TGM; Reinbold CS; Shin J; Scholz M; Håberg AK; Kämpe A; Li GHY; Avinun R; Atkins JR; Hsu FC; Amod AR; Lam M; Tsuchida A; Teunissen MWA; Aygün N; Patel Y; Liang D; Beiser AS; Beyer F; Bis JC; Bos D; Bryan RN; Bülow R; Caspers S; Catheline G; Cecil CAM; Dalvie S; Dartigues JF; DeCarli C; Enlund-Cerullo M; Ford JM; Franke B; Freedman BI; Friedrich N; Green MJ; Haworth S; Helmer C; Hoffmann P; Homuth G; Ikram MK; Jack CR; Jahanshad N; Jockwitz C; Kamatani Y; Knodt AR; Li S; Lim K; Longstreth WT; Macciardi F; ; ; Mäkitie O; Mazoyer B; Medland SE; Miyamoto S; Moebus S; Mosley TH; Muetzel R; Mühleisen TW; Nagata M; Nakahara S; Palmer ND; Pausova Z; Preda A; Quidé Y; Reay WR; Roshchupkin GV; Schmidt R; Schreiner PJ; Setoh K; Shapland CY; Sidney S; St Pourcain B; Stein JL; Tabara Y; Teumer A; Uhlmann A; van der Lugt A; Vernooij MW; Werring DJ; Windham BG; Witte AV; Wittfeld K; Yang Q; Yoshida K; Brunner HG; Le Grand Q; Sim K; Stein DJ; Bowden DW; Cairns MJ; Hariri AR; Cheung CL; Andersson S; Villringer A; Paus T; Cichon S; Calhoun VD; Crivello F; Launer LJ; White T; Koudstaal PJ; Houlden H; Fornage M; Matsuda F; Grabe HJ; Ikram MA; Debette S; Thompson PM; Seshadri S; Adams HHH
Cell Rep Med; 2024 May; 5(5):101529. PubMed ID: 38703765
[TBL] [Abstract] [Full Text] [Related]
6. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
7. Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes.
Abdelrahman Z; Abdelatty A; Luo J; McKnight AJ; Wang X
Comput Biol Med; 2024 Jun; 175():108304. PubMed ID: 38663352
[TBL] [Abstract] [Full Text] [Related]
8. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
9. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract] [Full Text] [Related]
10. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast cancer.
Wang R; Khatpe AS; Kumar B; Mang HE; Batic K; Adebayo AK; Nakshatri H
Cancer Res Commun; 2024 May; 4(5):1282-1295. PubMed ID: 38651826
[TBL] [Abstract] [Full Text] [Related]
11. Prion meeting 2023: implications of a growing field.
Outeiro TF; Vieira TCRG
Prion; 2024 Dec; 18(1):68-71. PubMed ID: 38651736
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
13. The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells.
Nakagawa-Saito Y; Mitobe Y; Togashi K; Suzuki S; Sugai A; Takenouchi S; Nakamura K; Sonoda Y; Kitanaka C; Okada M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612758
[TBL] [Abstract] [Full Text] [Related]
14. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
[TBL] [Abstract] [Full Text] [Related]
15. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
[TBL] [Abstract] [Full Text] [Related]
16. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
Kibe Y; Ohka F; Aoki K; Yamaguchi J; Motomura K; Ito E; Takeuchi K; Nagata Y; Ito S; Mizutani N; Shiba Y; Maeda S; Nishikawa T; Shimizu H; Saito R
Acta Neuropathol Commun; 2024 Apr; 12(1):57. PubMed ID: 38605367
[TBL] [Abstract] [Full Text] [Related]
17. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
18. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
20. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
[Next]
